XZMD:LSE:LSE-Xtrackers MSCI USA ESG UCITS ETF 1D (USD)

ETF | Others |

Last Closing

USD 10.4

Change

-0.01 (-0.09)%

Market Cap

USD 0.16B

Volume

3.74K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+1.00 (+0.45%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.52 (-1.09%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.08 (-0.54%)

USD 581.04B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.16 (-0.88%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.20 (+0.32%)

USD 266.08B
0QZO:LSE 0QZO

+0.70 (+0.64%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.25 (-0.84%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+0.36 (+0.23%)

USD 202.26B
0R24:LSE Intel Corp.

-0.04 (-0.18%)

USD 196.14B

ETFs Containing XZMD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.55% 23% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.55% 23% F 33% F
Trailing 12 Months  
Capital Gain 24.10% 82% B 81% B-
Dividend Return 1.18% 44% F 49% F
Total Return 25.28% 83% B 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 15.18% 78% C+ 78% C+
Dividend Return 15.23% 78% C+ 78% C+
Total Return 0.05% 32% F 30% F
Risk Return Profile  
Volatility (Standard Deviation) 13.83% 52% F 69% C-
Risk Adjusted Return 110.10% 95% A 97% N/A
Market Capitalization 0.16B 58% F 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.